Ou Qingqing, Cheng Jiang, Zhang Licui, Wang Huimin, Wang Wei, Ma Yajing
1 Medical College of Shihezi University, Shihezi, P.R. China.
2 Department of Clinical Laboratory, The First Affiliated Hospital, Shihezi University School of Medicine, Shihezi, P.R. China.
Tumour Biol. 2017 Jun;39(6):1010428317706214. doi: 10.1177/1010428317706214.
Breast cancer is one of the leading malignant tumors that endanger women's health worldwide. Despite the rapid progress on the therapies, including chemotherapy, surgical resection, and other auxiliary methods, there were still numerous people died of breast cancer, which promoted the researchers to concentrate on the prognostic factor of breast cancer. In recent years, an increasing number of studies have been focused on the prognostic value of pretreatment neutrophil-to-lymphocyte ratio in breast cancer. This article is a brief review of the associations between neutrophil-to-lymphocyte ratio and the prognosis of breast cancer patients, which may give a greater insight into the development of breast cancer and enable clinicians to cure it completely.
乳腺癌是全球范围内危害女性健康的主要恶性肿瘤之一。尽管在治疗方面取得了快速进展，包括化疗、手术切除及其他辅助方法，但仍有众多人死于乳腺癌，这促使研究人员专注于乳腺癌的预后因素。近年来，越来越多的研究聚焦于乳腺癌治疗前中性粒细胞与淋巴细胞比值的预后价值。本文简要综述中性粒细胞与淋巴细胞比值和乳腺癌患者预后之间的关联，这可能会让人们对乳腺癌的发展有更深入的了解，并使临床医生能够完全治愈它。
